Investors

Date	Name	Title	Type	Shares Traded	Price Range
Mar 9, 2011	mccorkle douglas s	Officer	Option Execute	9,400	20.32
Mar 9, 2011	shooter eric m	Director	Automatic Sell	27,500	40.00
Mar 9, 2011	shooter eric m	Director	Option Execute	27,500	18.61 - 28.81
Mar 4, 2011	terifay robert j	Officer	Automatic Sell	6,099	38.00
Mar 4, 2011	terifay robert j	Officer	Option Execute	6,099	21.92
Feb 18, 2011	goldberg murray a	Officer	Automatic Sell	4,569	36.87 - 37.29
Feb 17, 2011	goldberg murray a	Officer	Automatic Sell	10,281	37.78
Feb 17, 2011	goldberg murray a	Officer	Option Execute	14,850	19.43
Feb 17, 2011	terifay robert j	Officer	Automatic Sell	48,901	38.00
Feb 17, 2011	terifay robert j	Officer	Option Execute	48,901	21.34 - 21.92
Feb 14, 2011	goldberg murray a	Officer	Automatic Sell	5,885	35.97 - 37.42
Feb 14, 2011	terifay robert j	Officer	Automatic Sell	5,000	37.02
Feb 14, 2011	terifay robert j	Officer	Option Execute	5,000	21.34
Feb 11, 2011	goldberg murray a	Officer	Automatic Sell	14,115	36.06
Feb 11, 2011	goldberg murray a	Officer	Option Execute	20,000	19.43
Feb 11, 2011	goldstein joseph l	Director	Automatic Sell	2,761	36.66
Feb 10, 2011	goldstein joseph l	Director	Automatic Sell	2,239	35.27
Feb 10, 2011	goldstein joseph l	Director	Option Execute	5,000	15.80
Jan 27, 2011	goldstein joseph l	Director	Automatic Sell	5,401	34.67
Jan 26, 2011	goldstein joseph l	Director	Automatic Sell	4,599	34.35
Showing 381-400 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.